Ruth Wood, co-creator of the Honeycomb maze, describes how the new test overcomes the challenges of its predecessors, and how it can be utilized across the spectrum of neuroscience research.
Jeff describes how dysfunction in the glymphatic system could contribute to Alzheimer’s disease, and how our growing knowledge in this area could be harnessed to develop new disease-modifying treatments.
Discover the emerging field of biomaterials in regenerative strategies for spinal cord injury in this editorial Future Science OA.
Researchers have demonstrated that a tetraplegic patient can learn to adapt neural activity to maintain control of a brain-machine interface in the face of technical challenges.
Research presented today at SfN’s annual meeting has detailed advances in brain stimulation technologies revealing safer, more targeted means of studying brain function and treating neurological disorders.
Research presented at SfN’s Neuroscience 2017 has highlighted novel applications of genetic and cellular techniques that may help us to better understand neurological disorders such as addiction and Zika.
As part of our Spotlight on neuroregeneration, we spoke to Helen Budworth, Kent Fitzgerald and Kevin McCormack from the CIRM.
Jeffrey C. Hall, Michael Rosbash and Michael W. Young receive the award for their work on the molecular mechanisms controlling circadian rhythms.
Researchers have developed a 3D, all-human, in vitro model to help overcome challenges in delivering drugs to the brain.